DPIIT recognised startup Government of India
Startup India
Aviterium Immunology Private Limited
Aviterium Immunology Private Limited - chemicals in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.02 Lakh
▼ 58% YoY
Net loss · FY 2025
₹3.24 Lakh
Net margin -317.4%
EBITDA · FY 2025
-₹2.59 Lakh
EBITDA margin -253.4%
Authorised capital
₹4.99 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Aviterium Immunology Private Limited
Data last updated:
Aviterium Immunology Private Limited is a private limited company based in Nagpur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC340133. Its GSTIN is 27AATCA5047M1Z1 (Maharashtra).
The company has an authorised share capital of ₹4.99 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amruta Chetan Dhondse and Sonal Bhau Panchbhai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.373 P.No.70 W.No.2 Radke Layout Hingna Road Digdoh, Nagpur, Maharashtra, India – 440016.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹3.24 Lakh (net margin -317.4%) and EBITDA of -₹2.59 Lakh (EBITDA margin -253.4%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years.
Company details
CIN U24290MH2020PTC340133
Registration Number 340133
Incorporation Date 31 May 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Aviterium Immunology
Contact details
Aviterium Immunology Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.373 P.No.70 W.No.2 Radke Layout Hingna Road Digdoh, Nagpur, Maharashtra, India – 440016
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Aviterium Immunology Private Limited, buy the company report.
Comprehensive company report
Aviterium Immunology Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aviterium Immunology is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Aviterium Immunology Private Limited, buy the company report.
Financials of Aviterium Immunology Private Limited
FY 2025 filings availableAviterium Immunology Private Limited reported revenue of ₹1.02 Lakh (down 58% YoY) for FY 2025.
Revenue · FY 2025
₹1.02 Lakh ▼ 58%
Net loss · FY 2025
₹3.24 Lakh margin -317.4%
EBITDA · FY 2025
-₹2.59 Lakh margin -253.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 58%
3 years · compounded
▲ 74%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 12%
Revenue fell 58% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 74%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -253.4% | ||||
| Net Profit Margin | -317.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aviterium Immunology Private Limited, buy the company report.
Board of directors of Aviterium Immunology Private Limited
Aviterium Immunology has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amruta Chetan Dhondse | Director | 15 Dec 2020 | 5 Years 10 Months | Current |
| Sonal Bhau Panchbhai | Director | 31 May 2020 | 6 Years 4 Months | Current |
| Archana Manoj Raut | Director | 31 May 2020 | 6 Years 4 Months | Current |
| Manasi Ashish Mandaogade | Director | 31 May 2020 | 6 Years 4 Months | Current |
Peer comparison
Aviterium Immunology Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Smegy Polymers Private Limited | ₹1.15 Lakh (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Monesh Chemo Engineering Pvt Ltd | ₹1.15 Lakh (FY 2024) | 54.0% | Maharashtra, India | |||
| Cu-V-Kar Pharmacuticals Private Limited | ₹1.1 Lakh (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Dav Lifecare Private Limited | ₹1.07 Lakh (FY 2025) | 43.0% | Satara, Maharashtra, India | |||
| Cutyco India Private Limited | ₹1.06 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Aviterium Immunology Private Limitedthis company | ₹1.02 Lakh (FY 2025) | -₹3.24 Lakh | -317.4% | -58.0% | Nagpur, Maharashtra, India | |
| Goodheart Pharmachem Private Limited | ₹1 Lakh (FY 2025) | Jalgaon, Maharashtra, India | ||||
| Maxazan Healthcare Private Limited | ₹99,221 (FY 2025) | 133.0% | Lucknow, Uttar Pradesh, India | |||
| Aglenova Pharmaceutical Private Limited | ₹98,877 (FY 2025) | New Delhi, Delhi, India | ||||
| Skyvin Healthcare Private Limited | ₹98,836 (FY 2025) | -86.0% | Mumbai, Maharashtra, India | |||
| Getson Pharmaceuticals Private Limited | ₹98,510 (FY 2025) | 44.0% | Delhi, India |
To see the full peer comparison of Aviterium Immunology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aviterium Immunology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aviterium Immunology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aviterium Immunology Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Aviterium Immunology has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCA5047M1Z1 | Maharashtra | Active | 24 Feb 2021 |
To see the full GST registrations and return filing status of Aviterium Immunology Private Limited, buy the company report.
Recent activity
Aviterium Immunology Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Amruta Chetan Dhondse was appointed as Director on 15 Dec 2020.
AGM
Aviterium Immunology Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aviterium Immunology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Amruta Chetan Dhondse was appointed as Director.
Appointed
Archana Manoj Raut was appointed as Director.
Appointed
Manasi Ashish Mandaogade was appointed as Director.
Appointed
Sonal Bhau Panchbhai was appointed as Director.
Incorporation
31 May 2020
Aviterium Immunology Private Limited was registered on 31 May 2020 with Roc Mumbai & aged 6 years 5 months as per MCA records.
Frequently asked questions
Aviterium Immunology is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 May 2020 (6+ years old) and is registered under CIN U24290MH2020PTC340133.
Aviterium Immunology has 4 current directors:
- Amruta Chetan Dhondse - Director
- Sonal Bhau Panchbhai - Director
- Archana Manoj Raut - Director
- Manasi Ashish Mandaogade - Director
The latest financial statements of Aviterium Immunology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aviterium Immunology is 27AATCA5047M1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aviterium Immunology is U24290MH2020PTC340133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aviterium Immunology was incorporated on 31 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aviterium Immunology by revenue are Smegy Polymers Private Limited, Monesh Chemo Engineering Pvt Ltd, Cu-V-Kar Pharmacuticals Private Limited, Dav Lifecare Private Limited, Cutyco India Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Amruta Chetan Dhondse was appointed as Director on 15 Dec 2020. Archana Manoj Raut was appointed as Director on 31 May 2020. Manasi Ashish Mandaogade was appointed as Director on 31 May 2020. Aviterium Immunology has 4 board changes on record in total.
Yes, Aviterium Immunology is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Aviterium Immunology is at H.No.373 P.No.70 W.No.2 Radke Layout Hingna Road Digdoh, Nagpur, Maharashtra, India – 440016.
Aviterium Immunology operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages